Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CRNT vs CPSH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CRNT Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)
CRNT Overall Winner
6-Pillar Tally: CRNT 6 – 0 CPSH
Matrix Metrics: CRNT 8 – 2 CPSH
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over CPS Technologies Corp. (CPSH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.34 (13.7x Forward P/E, 3.5% operating margin), whereas CPSH carries 26.4/100 (SELL) at $3.67 (67.7x Forward P/E, -1.6% operating margin).
- Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CRNT (26.6/100 SELL) and CPSH (26.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
- Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile CPSH is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About CRNT vs CPSH
CRNT
Head-to-Head Winner
Ceragon Networks Ltd
$2.34
-2.09% 1D
Market Cap
$217.2M
TTM Revenue
$357M
Forward P/E
13.7x
Beta / 30D Vol
1.86β · 77% Vol
Unified Composite Score
26.6
SELL
Tech 50.0
Fund 35.0
Flow 58.0
Mom 50.0
Weinstein Technical Phase
Markup · Hold / add on dips
CPSH
CPS Technologies Corp. Common Stock
$3.67
-9.61% 1D
Market Cap
$79.6M
TTM Revenue
$32M
Forward P/E
67.7x
Beta / 30D Vol
3.08β · 83% Vol
Unified Composite Score
26.4
SELL
Tech 50.0
Fund 35.0
Flow 53.0
Mom 54.0
Weinstein Technical Phase
Distribution · Trim / tighten stop
6-Pillar Scorecard Institutional Category Breakdown (CRNT 6 – 0 CPSH)
1. Valuation Multiples
CRNT
Forward P/E
13.7x
67.7x
Trailing P/E
15.7x
70.9x
PEG Ratio
8.80x
N/M
EV / Revenue
0.6x
2.6x
2. Growth & Scale
CRNT
Revenue Growth (YoY)
+11.7%
+1.1%
Earnings Growth (YoY)
N/A
+78.6%
TTM Revenue (USD)
$357M
$32M
Market Cap
$217.2M
$79.6M
3. Profitability & Quality
CRNT
Gross Margin
34.1%
15.1%
Operating Margin
3.5%
-1.6%
Net Profit Margin
-0.3%
0.3%
Return on Equity (ROE)
-0.5%
0.4%
4. Balance Sheet & Cash Flow
CRNT
Cash Generation (TTM)
$13M
-$4.0M
Cash Flow Margin
3.6%
-12.2%
Net Cash / Leverage
$6.0M Net Cash
$6.1M Net Debt (0.26x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
CRNT
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
43.7% (7th %ile)
160.7% (62nd %ile)
Put/Call OI Skew
0.14x (Call-Skewed)
0.69x (Call-Skewed)
OBV Trend / Tech Phase
ACCUMULATION · Markup
NEUTRAL · Distribution
6. R&D & Supply-Chain Moat
CRNT
OpEx & R&D Intensity
30.6% of Rev ($109M)
16.7% of Rev ($5.4M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Communication Equipment Operator
Electronic Components Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: CRNT (8) vs CPSH (2)| Institutional Metric | CRNT | CPSH | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $217.2M | $79.6M | CRNT | |
| Trailing P/E Ratio | 15.7x | 70.9x | CRNT | |
| Forward P/E Ratio | 13.7x | 67.7x | CRNT | |
| Revenue Growth (YoY) | +11.7% | +1.1% | CRNT | |
| Operating Margin (TTM) | 3.5% | -1.6% | CRNT | |
| Net Profit Margin | -0.3% | 0.3% | CPSH | |
| Return on Equity (ROE) | -0.5% | 0.4% | CPSH | |
| 52-Week Range Position | 34% ($2–$3) | 6% ($3–$14) | CRNT | |
| Beta / 30D Volatility | 1.86β · 77% Vol | 3.08β · 83% Vol | CRNT | |
| Unified Institutional Score | 26.6 / 100 (SELL) | 26.4 / 100 (SELL) | CRNT | |
| Trailing 12M Revenue (USD) | $357M | $32M | Scale | |
| Gross Profit Margin (TTM) | 34.1% | 15.1% | Quality | |
| PEG Ratio & EV / Revenue | 8.80x PEG · 0.6x EV/Rev | N/M PEG · 2.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $13M ($6.0M Net Cash) | -$4.0M ($6.1M Net Debt (0.26x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
CRNT +10.15 pp
3M Horizon
CRNT +23.73 pp
6M Horizon
CRNT +24.63 pp
1Y Horizon
CRNT +2.44 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CRNT Revenue | CPSH Revenue | CRNT Op. Margin | CPSH Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $340M | $20M | 7.6% | -4.2% | CRNT |
| FY2019 | $290M | $20M | 2.6% | -2.8% | CRNT |
| FY2020 | $260M | $20M | -2.9% | 4.4% | CPSH |
| FY2021 | $290M | $20M | 1.7% | 2.3% | CPSH |
| FY2022 | $300M | $30M | -3.7% | 8.4% | CPSH |
| FY2023 | $350M | $30M | 6.1% | 6.2% | CPSH |
| FY2024 | $390M | $20M | 9.8% | -20.7% | CRNT |
| FY2025 | $340M | $30M | 2.1% | 1.4% | CRNT |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
CRNT
BREAKDOWN
Current IV
43.7%
IV Percentile
7th %ile
Put/Call OI Skew
0.14x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact CRNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CPSH
BREAKDOWN
Current IV
160.7%
IV Percentile
62nd %ile
Put/Call OI Skew
0.69x (Call-Skewed)
IV Regime
Elevated (60th–80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact CPSH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
CRNT Moat Profile
Cyclical / Execution-Driven Positioning
Communication Equipment Operator
OpEx & R&D Reinvestment
30.6% of Rev ($109M)
90D Engineering Disclosures
0 Published
CPSH Moat Profile
Cyclical / Execution-Driven Positioning
Electronic Components Operator
OpEx & R&D Reinvestment
16.7% of Rev ($5.4M)
90D Engineering Disclosures
0 Published
Investor FAQ CRNT vs CPSH Key Questions & Quantitative Answers
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over CPS Technologies Corp. (CPSH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.34 (13.7x Forward P/E, 3.5% operating margin), whereas CPSH carries 26.4/100 (SELL) at $3.67 (67.7x Forward P/E, -1.6% operating margin). Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CRNT (26.6/100 SELL) and CPSH (26.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile CPSH is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CRNT leads the Growth & Scale pillar: CRNT posts +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin), compared with CPSH at +1.1% YoY revenue growth and +78.6% YoY earnings growth on $32M TTM revenue (15.1% gross margin, -1.6% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CRNT cumulative revenue shifted +0.0% while CPSH shifted +50.0%. In operating R&D and SG&A reinvestment, CRNT deploys 30.6% of Rev ($109M) (0 90-day corporate R&D disclosures) versus 16.7% of Rev ($5.4M) (0 disclosures) for CPSH.
CRNT screens cheaper on headline valuation multiples. CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin), whereas CPSH trades at 67.7x Forward P/E, 70.9x Trailing P/E, N/M PEG, and 2.6x EV/Revenue (-12.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRNT (-0.5% ROE) versus CPSH (0.4% ROE) capital efficiency.
In options market volatility and institutional positioning, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.86β · 77% Vol realized risk). By comparison, CPSH carries 160.7% implied volatility (62nd %ile, Elevated (60th–80th %ile)), a 0.69x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.08β · 83% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CPSH vs CRNT · Reverse Pair
CRNT vs GILT
· Sector Peer
CRNT vs SENS
· Sector Peer
CRNT vs INSG
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking